A new study from Imperial College London has been published in the journal Nature Chemistry investigating the anti-rhinovirus activity of a novel compound. The paper, entitled ’Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus’ attracted significant media attention, and Peter was asked to give media statements as Spokesperson for the British Society for Immunology that were distributed via the Science Media Centre.
